Búsqueda avanzada

Iain James Mackay ocupa el cargo de Director Financiero y Director Ejecutivo en GlaxoSmithKline Plc y Director y Director Financiero en HSBC Holdings PLC (Hong Kong). También es miembro del tribunal de la Universidad de Aberdeen y del Instituto de Contables Colegiados de Escocia, y forma parte del consejo de administración de otras cinco empresas. Anteriormente ocupó el cargo de Director Ejecutivo y Director Financiero del Grupo en HSBC Holdings Plc Director Financiero de The HongKong & Shanghai Banking Corp. Ltd. Director Financiero de HSBC Asia Pacific Holdings (UK) Ltd. Director Financiero y Vicepresidente Ejecutivo Senior de HSBC Finance Corp. y Director Financiero y Vicepresidente Ejecutivo Senior de HSBC North America Holdings, Inc. (todas ellas filiales de HSBC Holdings Plc), Director Financiero para Europa, África y el Sudeste Asiático en Dowell Schlumberger, Director Financiero y Vicepresidente de Global Life Sciences Solutions Manufacturing UK Ltd. y Director Financiero y Vicepresidente de GE Consumer Finance, Inc. El Sr. Mackay se licenció en la Universidad de Aberdeen.

Iain Ruaraidh Mackay is currently a Director at Red Sixty One Ltd.
He previously worked as a Non-Executive Director at Pufferfish Ltd.

Iain Mackay currently works at GB Snowsport Ltd., as Director.

Michelle M.
MacKay is currently the Chief Executive Officer & Director at Cushman & Wakefield Plc, the Chief Executive Officer at Cushman & Wakefield, Inc., the Chief Executive Officer at Cushman & Wakefield Sweden AB, and the Co-President, Chief Operating Officer & Director at Cushman & Wakefield Debenham Tie Leung Ltd.
Previously, she served as an Independent Director at WCI Communities, Inc. from 2009 to 2017, an Executive Director-Commercial Real Estate at UBS Warburg, Inc. from 1998 to 2001, an Assistant VP-Real Estate & Fixed Income at The Hartford Financial Services Group, Inc. from 1991 to 1996, a Vice President at Chase Bank USA, NA from 1996 to 1998, and an Executive VP-Investments & Head-Capital Markets at iStar, Inc. from 2003 to 2017.
She also served as an Independent Trustee at Americold Realty Trust, Inc. from 2018 to 2021.
Ms. MacKay holds an undergraduate degree from the University of Connecticut and an MBA from the University of Hartford.

Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Alick Mackay is currently the Director of Strategy & Corporate Development at Brooks MacDonald Group Plc since 2017.
Prior to this, he worked as the Chief Operating Officer at NatWest Group Plc.
Mr. Mackay has an undergraduate degree from the University of Aberdeen, a graduate degree from The Open University, and an MBA from Columbia Business School.

El Dr. Iain D. Dukes es director general de Viriom, Inc., presidente y director de Kartos Therapeutics, Inc., director independiente de Ikena Oncology, Inc., socio de riesgo de OrbiMed Advisors Private Equity, presidente de Iovance Biotherapeutics, Inc., presidente ejecutivo de Theseus Pharmaceuticals, Inc. y presidente y director general de Arrys Therapeutics, Inc. Es miembro del Consejo de Administración de Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. y ReViral Ltd. Anteriormente, el Dr. Dukes fue miembro del Consejo de Supervisión de Themis Bioscience GmbH, Vicepresidente Senior y Jefe de Desarrollo Comercial de Merck Research Laboratories Massachusetts LLC, Vicepresidente de Investigación y Desarrollo Externo de Amgen, Inc, Presidente y Director General de Essentialis, Inc., Vicepresidente de Licencias Científicas y Tecnológicas de GlaxoSmithKline, Inc., Jefe de Desarrollo Exploratorio de Glaxo Wellcome, Inc., Director de Glaxo, Inc. y Vicepresidente Senior de Desarrollo Comercial y Licencias de Merck & Co. También formó parte del consejo de administración de KaNDy Therapeutics Ltd. Se licenció en la Universidad de Bath, se licenció en la Universidad de Oxford, se licenció en la Universidad de Leeds y se doctoró en la Universidad de Oxford.

Iain G. T. Ferguson es un empresario que ha estado al frente de 11 empresas diferentes y actualmente es presidente no ejecutivo de Genus Plc, presidente no ejecutivo de Crest Nicholson Holdings Plc, presidente no ejecutivo de Crest Nicholson Plc (filial de Crest Nicholson Holdings Plc) y presidente de Hallmarq Veterinary Imaging Ltd. El Sr. Ferguson también es rector de la Universidad de Cranfield y forma parte del consejo de administración de otras cinco empresas. En su anterior carrera, Iain G. T. Ferguson ocupó el cargo de Presidente no ejecutivo de Stobart Group Ltd., Director General de Tate & Lyle Plc, Vicepresidente Senior de Desarrollo Corporativo de Unilever Plc, Presidente no ejecutivo de Berendsen Ltd., Director General de Birds Eye Ltd, Miembro de PricewaterhouseCoopers LLP (Reino Unido), miembro del Grupo de Estrategia del Departamento de Negocios, Innovación y Habilidades del Reino Unido, presidente de Wilton Park, presidente del Instituto de Distribución de Comestibles y presidente de la Federación de Alimentos y Bebidas. El Sr. Ferguson se licenció en la Universidad de St.

Iain Rob Rayner ocupa el cargo de Director General Adjunto de Operaciones de St. James's Place Plc. El Sr. Rayner también forma parte del consejo de administración de St. Jamess Place Acquisition Services Ltd. y de St. James's Place DFM Holdings Ltd.

Iain Wetherall ocupa el cargo de Director de Inversiones de Wizz Air Holdings Plc.

En la actualidad, Iain Boyd ocupa el cargo de Vicepresidente de Desarrollo de Operaciones en Snap-On, Inc. Anteriormente ocupó el cargo de Vicepresidente de Recursos Humanos de Snap-on Tools Co. LLC.

En la actualidad, Iain George Williamson es Director General y Director Ejecutivo de Old Mutual Ltd. y Director General de Old Mutual Life Assurance Co. (Sudáfrica) Ltd. (filial de Old Mutual Ltd.) y Director General de Old Mutual Life Assurance Co. Ltd. También forma parte del consejo de administración de Nedbank Group Ltd., Nedbank Ltd. y UAP Old Mutual Group Ltd. El Sr. Williamson ocupó anteriormente el cargo de Director Financiero de Old Mutual Emerging Markets Ltd.

Iain C. Conn forma parte del consejo de BT Group Plc y Oxford Flow Ltd. y es miembro de la Mesa Redonda Europea de Industriales. En el pasado, el Sr. Conn fue Director General y Director Ejecutivo de Centrica Plc, Director Ejecutivo y Director General de Marketing y Refinación de BP Plc y Director General de BP Petrochemicals Ltd. (una filial de BP Plc). (filial de BP Plc) y miembro del Consejo del Imperial College London. Se licenció en el Imperial College de Londres.

Iain Charles Andrew Cornish es un empresario que ha estado al frente de 6 empresas diferentes. En la actualidad, es presidente de Leeds Building Society. El Sr. Cornish es también tesorero y fideicomisario de Macmillan Cancer Support y forma parte del consejo de administración de otras 5 empresas. James's Place Plc, presidente de Shawbrook Group Plc y presidente de Shawbrook Bank Ltd. (filial de Shawbrook). (filial de Shawbrook Group Plc), Director General de Yorkshire Building Society y Presidente de Building Societies Association. Se licenció en la Universidad de Southampton.

Iain Michael Brown ocupa el cargo de Vicepresidente Senior, Director Financiero y Contable en Alkermes Plc. En su anterior carrera, el Sr. Brown ocupó el cargo de Vicepresidente de Finanzas de Alkermes, Inc. y Vicepresidente de Finanzas de EMD Serono, Inc. Se licenció en la Universidad de Bradford.

En la actualidad, Iain Blacklaw ocupa el cargo de Director de Operaciones del National Bank of Bahrain. En el pasado ocupó el cargo de Director de Operaciones del Al Rajhi Bank. Se licenció en la Universidad de Aberdeen.

Iain - has worked as the Chairman at Mirion Technologies (IST France) SAS since 2011.

Erick Mackay currently works as a Marketing Director at Daisy IT Managed Services Ltd.

Ms. Mackay joined Legg Mason Canada in 2004.
She holds the Chartered Financial Analyst designation.

Harvey B.
Mackay is currently the Chairman of MackayMitchell Envelope Co. and a Director of Minnesota Orchestral Association.

Mr. Kevin J.
MacKay is a Sales Associate at Computer Economics, Inc. Mr. MacKay was previously employed as Chief Accounting Officer, VP & Controller by Avaya, Inc., Chief Accounting Officer, VP & Controller by Avaya Holdings Corp., a Principal by iBASEt, a Principal by Logility, Inc., and a Principal by Oracle Corp.

Mark B.
Mackay worked as Vice President-Engineering & Construction at TransAlta Corp.
from 2012 to 2020.
Prior to that, he worked as Vice President at TransCanada PipeLines Ltd.
Mr. Mackay completed his undergraduate degree at the University of British Columbia.

Danny Colin Keith MacKay is currently the Chief Executive Officer at Tactical Software Systems Pty Ltd., Chairman at Quadrem Africa Pty Ltd., Director at Black Information Technology Empowerment Co. Ltd., and Director at Ariba South Africa.
He previously worked as a Non-Executive Director at EOH Holdings Ltd.
from 2014 to 2017.

Jeffrey K.
MacKay worked as a Treasurer & Vice President at The Dayton Power & Light Co. and DPL, Inc.

Catherine Mackay currently works at Amplify Education, Inc., as President & Chief Operating Officer from 2018.

Derek C.
Mackay worked as a Vice President-Finance at ONEX Corp.
and as a Senior Associate at PricewaterhouseCoopers LLP (Canada).
He completed his undergraduate degree at Wilfrid Laurier University.

Jason M.
Mackay is currently a Director at Adderstone (201) Ltd.
Prior to this, he was a Non-Executive Director at Audioboom Group Plc from 2014 to 2017.
He also held positions as Head of UK Equities at GLG Partners LP and Co-Head of UK Equities at Man Group Investments Ltd.
from 2004 to 2010.

Margaret MacKay is currently a Non-Executive Director at Scottish Building Society since 2017.
Prior to this, she worked as a Managing Director at Clydeport Ltd.

Carla Mackay worked as the Chief Financial Officer at Invictus Energy Ltd.
from 2013 to 2014.
She obtained an undergraduate degree from the University of Johannesburg.

Douglas Duffy MacKay held the following former jobs: Senior VP-Scientific & Regulatory Affairs at CV Sciences, Inc. from 2019 to 2021, Senior VP-Scientific & Regulatory Affairs at Council for Responsible Nutrition from 2008 to 2018, and Vice President-Clinical Research at Nordic Pharma, Inc. AS from 2004 to 2008.
He received his undergraduate degree from the University of California, Santa Cruz in 1994 and his doctorate degree from National College of Natural Medicine in 2001.

James M.
Mackay is the founder of Aristea Therapeutics, Inc. (founded in 2018) where he holds the title of President & Chief Executive Officer.
He is currently the Chairman at CONNECT since 2014, Director at BIOCOM, Director at MatriSys Bioscience, Inc. (since 2020), Director at Arthrosi Therapeutics, Inc. (since 2021), and Independent Director at Privo Technologies, Inc. Dr. Mackay previously served as President & Chief Executive Officer at Ardea Biosciences, Inc. (2013-2018), Director & Trustee at San Diego Regional Economic Development Corp.
(2017-2018), and Vice President-Global Product at AstraZeneca PLC (2008-2016).
He obtained undergraduate and doctorate degrees from the University of Aberdeen.

Giles Patrick Cyril Mackay is currently a Director at ResiManagement Ltd., PXS 3 Ltd., Heylo Housing Secured Bond Plc, Heylo Housing Group Ltd., GPCM Holdco Ltd., GPCM Finco Ltd., Statuslist Ltd., Worthearly Ltd., Assettrust Ltd., HH No.
3 Ltd., HH No.
2 Ltd., and HH No.
5 Ltd.
He was formerly a Director at Hometrack Co. UK Ltd.

Billy Mackay is the founder of Boon Co., Inc. He is currently working as the Managing Director-Advised at AJ Bell Plc.

Thomas Mackay is currently the Chief Financial Officer, Director & SVP at Virgin Atlantic Airways Ltd.
He is also a Director at Virglease Ltd., Virgin Travel Group Ltd., Virglease (3) Ltd., Junopart Ltd., VA Cargo Ltd., Virgin Atlantic Two Ltd., and Virgin Atlantic International Ltd.
Previously, he served as the Chief Financial Officer & Director at Virgin Atlantic Ltd.

Ian Mackay is the founder of Manaccom Pty Ltd.
He previously worked as the Executive Deputy Chairman at Jumbo Interactive Ltd.

Malcolm MacKay currently works at Sheltering Arms Children & Family Services, Inc., as Director.

Anthony Mackay is the founder of Kryptos-X Pte.
Ltd.
He currently serves as the Chairman-Emeritus at CXGH LLC.
Previously, he worked as a Non-Executive Director at Fatfish Group Ltd.
from 2018 to 2019.

Colin Mackay currently works at Elian Fiduciary Services (Cayman) Ltd., as Chief Executive Officer from 2011 and Maclay Murray & Spens LLP.
Mr. Mackay also formerly worked at EMR Capital Pty Ltd., as Board Director and Ogier Group LP, as Partner.
Mr. Mackay received his graduate degree in 1991 from the University of Glasgow.

Andrew Ryan MacKay is currently working as a Vice President & Global Credit Strategist at Loomis, Sayles & Co. LP.
He started this job in 2018.
In terms of education, Mr. MacKay completed his undergraduate degree at the University of New Hampshire.
He also obtained an MBA from the Wallace E Carroll School of Management in 2002.

Matthew B.
MacKay is the founder of Surge LLC, where he currently holds the title of Chief Executive Officer since 2007.
Mr. MacKay is also the founder of Remedy Informatics, Inc...
Mr. MacKay's former job positions include Software Engineer at PACCAR, Inc. and Vice President at TenFold Corp.
Mr. MacKay obtained his undergraduate degree from Brigham Young University.

Gavin Mackay worked as Head of Investor Relations and Business Development at Aquarius Platinum Ltd.
in 2011 and as Head of Business Development and Investor Relations at Ferrexpo Plc.
Mr. Mackay completed his undergraduate degree at the University of Cape Town and his graduate degree at the University of the Witwatersrand.